Conditions: Metastatic Differentiated Thyroid Cancer Metastatic Poorly Differentiated Thyroid Cancer Metastatic Anaplastic Thyroid Cancer Metastatic Medullary Thyroid Cancer
Keywords: Thyroid Cancer Anaplastic Medullary sorafenib
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 59
Healthy volunteers: no

Brief summary:
The goal of this study is to determine the activity of sorafenib in patients with advanced (metastatic or recurrent) thyroid cancer.

Detailed description:

Arms:
arm 1: This is a single arm study.

Interventions: intervention 1: sorafenib
Intervention descriptions: intervention 1: 400mg PO BID daily

Protocol document: